• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. ASAHI REXEED-S SERIES DIALYZERS; DIALYZER, HIGH PERMEABILITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. ASAHI REXEED-S SERIES DIALYZERS; DIALYZER, HIGH PERMEABILITY Back to Search Results
Model Number APS-11SA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Shock (2072)
Event Date 03/06/2021
Event Type  Injury  
Manufacturer Narrative
The product of this event was not returned to the manufacturer and could not be analyzed; however, we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found and no similar event has been reported with this lot number globally so far.The physician determined, this event as "serious injury" and these described adverse events as anaphylactoid reactions.We determined to report this incident since we also consider anaphylactoid reactions as "serious injury" and the causal relationship between the anaphylactic reaction and the use of the medical device cannot be denied "anaphylactoid reaction" or "shock" are not written in adverse reactions in ifu of rexeed-s, but it is described regarding hypersensitivity and hypotension as "patients with a history of hypersensitivity reactions or those prone to hypersensitivity should be carefully monitored by the physician.It is recommended that, based on the physicians directions, treatment should be discontinued if signs or symptoms of hypersensitivity are exhibited." and "side effects such as hypertension, hypotension, headache, and nausea that may be associated with hypovolemia or hypervolemia can usually be avoided by careful management of the patient's fluid, electrolyte balance, blood flow rate, and transmembrane pressure (tmp)." we will continue to monitor the occurrence of similar events carefully.
 
Event Description
This incident occurred in (b)(6).Aps-sa series is identical model to rexeed-s series marketed in us.On (b)(6) 2021, at 9:28: the patient complained of feeling poorly and anaphylactoid reaction occurred 2 to 3 minutes after initiation of dialysis using other company's product.On (b)(6) 2021, at 9:39: 100 ml of fluid replacement was administered to increase blood pressure, but there was no improvement.On (b)(6) 2021, at 9:40: code blue was announced.Blood return was performed, and the patient was admitted to the icu.After the blood return, breathing and blood pressure were promptly recovered and code blue was released.On (b)(6) 2021: since hemodialysis was discontinued the day before, hemodialysis was performed using aps-11sa this time.The treatment was performed without any problems.On (b)(6) 2021, at 10:52: hemodialysis was initiated using aps-11sa.On (b)(6) 2021, at 10:55: the patient complained of numbness in upper and lower extremities and feeling poorly.Blood pressure decreased from 159 mmhg to 100 mmhg.Due to anaphylactoid reaction in patients, code blue was announced.On (b)(6) 2021, 10:57: blood return was started.On (b)(6) 2021, 11:09: hemodialysis was completed.The patient was intubated due to decreased spo2, and oxygenation was administered.After the ct scan was performed, the patient was admitted to the icu and at admission, consciousness level improved.There were no findings in ct scan, and blood pressure was recovered.On (b)(6) 2021, at 12:00: hemodialysis was performed with parnaparin sodium using other company's product for 3 hours without any problems.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASAHI REXEED-S SERIES DIALYZERS
Type of Device
DIALYZER, HIGH PERMEABILITY
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
2111-2
oaza sato
oita-shi, 870-0 396
JA   870-0396
Manufacturer Contact
naomi kagami
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0-006
JA   100-0006
MDR Report Key11606748
MDR Text Key260833932
Report Number8010002-2021-00020
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K153344
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2023
Device Model NumberAPS-11SA
Device Catalogue NumberN/A
Device Lot NumberXK6H6R
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/08/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/26/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age54 YR
Patient Weight68
-
-